CYTK - Cytokinetics Inc

-

$undefined

N/A

(N/A)

Cytokinetics Inc NASDAQ:CYTK Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.

Location: 280 E Grand Ave, California, 94080-4808, US | Website: www.cytokinetics.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

5.794B

Cash

1.057B

Avg Qtr Burn

-99.77M

Short % of Float

13.27%

Insider Ownership

0.50%

Institutional Own.

-

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Aficamten (CK-274) (cardiac myosin inhibitor) Details
Heart disease, Hypertrophic cardiomyopathies

NDA

Submission

Omecamtiv Mecarbil (cardiac myosin activator) Details
Pancreatic cancer, Heart disease, Heart failure

NDA

FDA meeting

Phase 2

Initiation

CK-3828136(CK-136) (cardiac troponin activator) Details
Heart failure, Heart disease, Epilepsy

Phase 1

Data readout

Failed

Discontinued